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Abstract
The peritoneal cavity (PerC) is a singular compartment where many cell populations reside and interact. Despite the widely
adopted experimental approach of intraperitoneal (i.p.) inoculation, little is known about the behavior of the different cell
populations within the PerC. To evaluate the dynamics of peritoneal macrophage (MØ) subsets, namely small peritoneal MØ
(SPM) and large peritoneal MØ (LPM), in response to infectious stimuli, C57BL/6 mice were injected i.p. with zymosan or
Trypanosoma cruzi. These conditions resulted in the marked modification of the PerC myelo-monocytic compartment
characterized by the disappearance of LPM and the accumulation of SPM and monocytes. In parallel, adherent cells isolated
from stimulated PerC displayed reduced staining for b-galactosidase, a biomarker for senescence. Further, the adherent cells
showed increased nitric oxide (NO) and higher frequency of IL-12-producing cells in response to subsequent LPS and IFN-c
stimulation. Among myelo-monocytic cells, SPM rather than LPM or monocytes, appear to be the central effectors of the
activated PerC; they display higher phagocytic activity and are the main source of IL-12. Thus, our data provide a first
demonstration of the consequences of the dynamics between peritoneal MØ subpopulations by showing that substitution
of LPM by a robust SPM and monocytes in response to infectious stimuli greatly improves PerC effector activity.
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Introduction
The mouse peritoneal cavity (PerC) is a unique environment
characterized by the co-habitation and interaction of many cell
types, like within secondary lymphoid organs. In steady state
conditions, the majority of peritoneal cells (PC) are macrophages
(MØ) and B-1 cells; conventional B-2 cells, T cells, natural killer
(NK) cells, dendritic cells (DC) and granulocytes (mostly
eosinophils) are also present [1,2]. In addition to the complexity
of the cellular composition in the PerC, we have recently
demonstrated that peritoneal MØ comprise two distinct subsets
named small peritoneal MØ (SPM) and large peritoneal MØ
(LPM) [1]. SPM and LPM differentially express a variety of
surface markers, including pattern recognition receptors (PRR)
and proteins involved in antigen presentation and cell migration
[1]. Importantly, SPM and LPM appear to have distinct responses
to LPS stimulation in vitro and in vivo, indicating that these
peritoneal MØ cannot be considered a single population.
As a heterogeneous population, MØ play a wide range of roles
in the immune system; they are involved in the removal of
apoptotic cells and cellular debris under steady state conditions
[3], microorganism ingestion and elimination [4,5], antigen
presentation and consequent T cell activation [6,7], resolution of
inflammatory processes, angiogenesis and tissue repair [8]. The
functionality of MØ subsets is influenced by factors that include
their maturation state and activation profile.
The maturation state influences the functional behavior of MØ;
their performance is particularly compromised as they age [9–14].
Age-related debilitation is reflected in activities associated with MØ
microbicidal function, including impairment in phagocytic ability
and in the production of inflammatory cytokines, chemokines and
free radicals; additionally, expression of MHCII molecules is
diminished, which may contribute to poor CD4
+ T cell responses.
Morphologically, senescent MØ adopt a flattened, enlarged
morphology and exhibit molecular markers like the senescence-
associated b-galactosidase (b-gal) [15]. Accumulation of senescent
MØ can compromise the tissues architecture and fitness [9–13].
MØ subsets can assume distinct functional profiles depending
on environmental stimuli. Classically-activated MØ, also known as
M1 MØ, are generated in the presence of LPS and IFN-c; they
exhibit high microbicidal ability and secrete pro-inflammatory
cytokines [16–19]. Conversely, alternative or M2 MØ are
generated in the presence of immune-complexes (IC) or Th2
cytokines and appear to be responsible for the control of
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22141inflammatory processes and tissue repair. They have also been
implicated in managing helminth infections [20,21].
It is reasonable to assume that in each tissue, MØ develop
particular characteristics and become capable of unique functions.
For instance, osteoclasts have the unique capacity for bone
remodeling, alveolar MØ possess the ability for self/non self
discrimination and lamina propria MØ exhibit high microbicidal
and phagocytic capacities coupled with low production of pro-
inflammatory cytokines [5]. However, distinct MØ subpopulations
have been found in the same environment [1,5], and little is known
about their relative contribution to tissue/organ function. Since the
majority of studies focus on in vitro MØ activities, many questions
about MØ behavior and function inside tissue microenvironments
remain unsolved. In the present work, we examined the dynamics
between SPM and LPM within the PerC in response to exposure to
zymosan, an insoluble carbohydrate from the cell wall of yeast, and
live Trypanosoma cruzi (T. cruzi) parasites.
Materials and Methods
Mice and parasites
Six- to eight-week-old female C57BL/6 mice were bred in our
animal facilities at the University of Sa ˜o Paulo under standard
pathogen-free conditions. All animal studies and protocols were
approved by the University of Sa ˜o Paulo Committee for the Use
and Care of Animals (Number 109/07). T. cruzi trypomastigotes of
the Sylvio-X10/4 strain were purified from LLC-MK2 cells (a
monkey epithelial cell line derivative from American Type Culture
Collection (ATCC CCL-7), USA).
Peritoneal cell suspensions
Peritoneal cells (PC) were harvested by flushing the PerC of
mice, as previously described [22]. Total PC and purified
peritoneal MØ subsets obtained after cell-sorting were cultured
in RPMI 1640 (Sigma-Aldrich, St. Louis, MO) supplemented with
L-glutamine (2 mM) and 3% heat-inactivated fetal calf serum
(FCS) at 37uC and 5% CO2. All supplements were purchased from
Life Technologies (Rockville, MD).
In vivo stimulation
For in vivo stimulation assays, mice were injected i.p. with
zymosan particles (1 mg/mouse) or T. cruzi trypomastigotes of the
Sylvio-X10/4 strain (10
6 parasites/mouse). PC were harvested
after 30 min or 48 h.
In vitro stimulation
Total PC (10
6 cells) from naive or in vivo-inoculated mice were
cultured for 10 h in the presence of brefeldin A (BD Biosciences,
Heidelberg, Germany) at 37uC and 5% CO2. Cells were
stimulated with LPS from Escherichia coli (Sigma-Aldrich) (1 mg/
mL) and rIFN-c (5 ng/mL) (BD Biosciences). Purified MØ subsets
(2610
5) were cultured in 8-well chambers for 12 h at 37uC and
5% CO2. Next, cells were fixed and labeled according to the
InstantProv KIT (NewProv, Brazil) instructions.
Flow cytometry
Cells were phenotypically analyzed by flow cytometry as
previously described [23], with some modifications. Briefly, cell
suspensions were stained for 30 min with a combination of
following biotin- or fluorochromes- conjugated monoclonal
antibodies (mAbs): fluorescein-isothiocyanate (FITC)-labeled anti-
F4/80 (CI:A3-1) (Serotec, Du ¨sseldorf, Germany); phycoerythrin
(PE)-labeled anti-CD80 (16-10A1), anti-CD86 (GL1), anti-CD40
(3/23), anti-CD11b (M1/70), anti–IA
b (AF6-120.1) or anti-LY6C
(AL-21) (BD Biosciences); allophycocyanin (APC)-labeled anti-
CD19 (1D3) (BD Biosciences), PerCP- conjugated anti-CD11c
(HL3) (BD Biosciences) and biotin-conjugated anti–IA
b (AF6-
120.1), anti-TLR-4 (MTS510), anti-DC-Sign (5H10/CIRE) (BD
Biosciences) or anti-Dectin-1 (2A11) (Serotec). For the detection of
biotinylated antibodies, streptavidin-Alexa Fluor 405 (BD Biosci-
ences) was used. For the detection of intracellular IL-12, PC were
stained using the combination of FITC-labeled anti-F4/80, APC-
labeled anti-CD19, PerCP- labeled anti-CD11c (HL3) and biotin-
conjugated anti–IA
b (AF6-120.1) as described above, fixed with
Cytofix (BD Biosciences) for 20 min, and then incubated with PE-
labeled polyclonal anti-mouse antibodies against IL-12p70 (C15.6)
(BD Biosciences) for 30 min in Cytoperm buffer (BD Biosciences)
[24]. For all experiments, 2610
5 events were acquired. All
acquisitions were performed using a 5-color staining combination
and acquired on FACSCalibur or FACSCanto II (BD Bioscienc-
es). Analysis was carried out with FlowJo software (Tree Star).
Fluorescence-minus-one (FMO) controls [23,25] were used to
distinguish positive staining from autofluorescent cells. Peritoneal
MØ subsets were sorted using a FACSVantage (BD Biosciences),
according to the parameters described in Fig. S1.
Adherent-cell culture
PC obtained from control and injected animals (6610
5 cells)
were incubated in 96-well plates (Costar) for 4 h at 37uC and 5%
CO2. The non-adherent cells were removed by vigorous washes
with RPMI medium.
Nitric Oxide measurement
Adherent PC from control and injected mice were cultured with
medium, LPS from Escherichia coli (Sigma-Aldrich) (1 mg/mL) or
LPS plus rIFN-c (5 ng/mL) (BD Biosciences); supernatants were
harvested after 48 h. Culture supernatants were assayed for NO by
the Griess reaction. Briefly, 50 ml of supernatant was incubated with
50 ml of Griess reagent for 5 min at room temperature. Nitrite
concentration was determined by measuring the optical density at
550 nm in reference to a standard sodium nitrite solution.
b-Galactosidase (b-Gal) staining
b-Gal staining was performed following the conventional
protocol for senescence associated (SA)-b-gal staining [15]. Briefly,
adherent-PC from naive or injected mice were fixed in 2%
formaldehyde/0.2% glutaraldehyde for 5 min at room tempera-
ture, washed with PBS and then incubated overnight at 37uC with
b-Gal staining solution at pH 6.0. b-Gal solution was composed of
1 mg/mL of X-gal (5-bromo-4-chloro-3 indolyl–galactopirano-
side); 40 mM of citric acid/sodium phosphate, pH 6.0; 150 mM
sodium chloride; 2 mM magnesium chloride; 5 mM potassium
ferrocyanide; and 5 mM potassium ferricyanide. Cells were
observed by phase contrast on a Nikon TS100 microscope and
photographed at 406magnification.
Statistical analysis
Statistical analyses were performed using the unpaired analysis
of variance ANOVA (Tukey Test) test. Differences between two
groups were considered significant when p,0.05.
Results
F4/80 and MHCII expression distinguishes LPM and SPM
Utilizing a high-dimensional digital FACS with 11-color
combination, we recently demonstrated that peritoneal MØ
comprises two distinct subpopulations, namely large (LPM) and
small peritoneal MØ (SPM); these subpopulations have pheno-
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demonstrate that these two subpopulations can also be identified
using a 4-color flow cytometry staining panel. First, doublet cells
(Fig. 1A) and CD19
high cells (Fig. 1B) were excluded. Next,
CD11c
high cells were excluded to eliminate remaining DC
(Fig. 1C). The Side Scatter (SSC) profile and F4/80 expression
revealed two distinct F4/80
+ subpopulations among CD19
neg/
verylowCD11c
neg/verylow cells (Fig. 1D). In addition, analysis of F4/
80
+ cells according to MHCII (IA
b) expression defined three
distinct subpopulations (Fig. 1E). Sorting of each population
revealed that F4/80
highIA
b-neg, F4/80
lowIA
b-high and F4/80
lowIA
b-
neg correspond, respectively, to LPM, SPM and granulocytes
(mostly eosinophils) (Fig. 1F). After 12 h in culture, SPM acquire a
polarized morphology whereas LPM exhibit prominent vacuol-
ization. Granulocytes appear to die after in vitro culture (Fig. 1G).
As granulocytes present a typical SSC profile with no MHCII
expression (Fig. 1F and Fig. S1A), F4/80
+ cells were gated to
exclude F4/80
lowSSC
high cells to establish the efficient identifica-
tion of peritoneal MØ subsets (Fig. S1B). Using a 5-color flow
cytometry staining panel, we observed that SPM and LPM
displayed the typical expression of surface markers, as previously
demonstrated [1] (Table 1). In addition to the previous published
phenotypic features [1], higher expression of the endocytic
receptors Dectin-1 and DC-Sign (dendritic cell-specific intercellu-
lar adhesion molecule-grabbing nonintegrin, CD209) was ob-
served in SPM as compared to LPM (Table 1).
Figure 1. Identification of resident peritoneal MØ subsets. PC from C57BL/6 were harvested and stained with fluorochrome-labeled
antibodies directed against F4/80, CD19, CD11c and IA
b for flow cytometry analysis. (A) Doublet cells were excluded according to forward scatter
profiles (FSC-A and FSC-H). Subsequently, (B) CD19
high cells and (C) CD11c
high cells were also excluded, and (D) F4/80
+ cells were selected. (E) F4/80
and IA
b expression defined three populations: LPM (F4/80
highIA
b-neg), SPM (F4/80
lowIA
b-high) and granulocytes (F4/80
lowIA
b-neg). These three
subpopulations were purified by cell sorting on a FACS Vantage, and their morphology was evaluated ex vivo from cytospin slides (F), or after in vitro
culture in chamber slides for 12 h (G). Slides were stained with hematoxylin and eosin (H&E) and analyzed by optical microscopy (406).
doi:10.1371/journal.pone.0022141.g001
Table 1. Phenotypic analysis of resident peritoneal MØ
subsets.
Surface molecule LPM SPM
F4/80 1970 90
CD11b 1700 30
IA
b (MHC-II) =FMO 3100
CD80 140 100
CD86 250 10
CD40 270 230
TLR4 150 80
DC-Sign 10 100
Dectin-1 840 1600
Ly6C =FMO =FMO
SPM and LPM were gated as shown in Figure 1 and the median fluorescence
intensity (MFI) of F4/80, CD11b, IA
b, CD80, CD86, CD40, LY6C, DC-SIGN, Dectin-1
and TLR4 was analyzed by flow cytometry. All acquisitions were performed
using a 5-color staining combination. The value for the expression of each
surface marker was obtained by subtracting the MFI of the fluorescence-minus-
one control (FMO) from the MFI of the whole stained cell population [23,25], as
described in the Materials and Methods (M&M) section. Data are representative
of more than 3 independent experiments.
doi:10.1371/journal.pone.0022141.t001
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between SPM and LPM
The PerC is a dynamic compartment that selectively attracts
immune cells, particularly in response to injury, which can result in
major alteration in their cellular composition. To evaluate the
dynamics ofLPMand SPMin response to infectiousstimuli, C57BL/
6 mice were injected i.p. with zymosan or live T. cruzi trypomasti-
gotes, and PC were collected after 30 min or 48 h. Minor alterations
Figure 2. Zymosan and T. cruzi injection alters the MØ compartment of PerC. C57BL/6 mice were injected i.p. with zymosan (1 mg/mouse)
or T. cruzi (10
6 parasites/mouse) and at 30 min (A)o r4 8h( B) after stimulation, PC from naive and injected mice were harvested and stained as
described in M&M. Sequential gates were made as shown in Fig. S1. Plots show the frequencies of each subpopulation. (C) F4/80
lowMHCII
int cells
present within PerC 48 h after injections were evaluated according the expression of Ly6C. Gray lines represent FMO [23,25], the black lines show F4/
80
lowMHCII
int cells from zymosan- (hairline) or T. cruzi-(bold line)-exposed PerC. (D) Total numbers of SPM, LPM and monocytes 48 h after zymosan or
T. cruzi exposure (within MØ gate) are shown in panel. Data are representative of more than 3 independent experiments.
doi:10.1371/journal.pone.0022141.g002
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after i.p. injections (Fig. 2A and data not shown); however, an
increase in the frequency of SPM in response to zymosan was
observed (Fig. 2A). Conversely, 48 h after zymosan and T. cruzi
exposure there was a clear alteration in the myelo-monocytic cell
compartment of the PerC, characterized by a dramatic decrease in
the numbers of LPM coupled with increased frequency of SPM
(Fig. 2B and 2D). Moreover,a massive influxof cellswith a monocytic
phenotype (F4/80
lowMHCII
intLy-6C
+) was noted (Fig. 2B, 2C and
2D). Since both SPM and monocytes that infiltrate PerC showed
same levels of F4/80, they were distinguished by Ly-6C and MHCII
e x p r e s s i o n .S P Md i s p l a y e dh i g hl e v e l so fM H C I Ia n dL y - 6 C
expression was found only on monocytes (Fig. 2B, 2C and Table 1).
The enrichment of monocytes was particularly observed after
zymosan exposure when F4/80
lowMHCII
intLy-6C
+ cells became
the dominant population in the PerC (Fig. 2D). Interestingly, 48 h
after T. cruzi stimulation, cells displaying the phenotypic features of
SPM (F4/80
lowMHCII
hiLy-6C
2) become the major peritoneal
myeloid cell population (Fig. 2B and 2D). Despite the fact that T.
cruzi and zymosan induce distinct modifications in the PerC, both
stimuli led to SPM dominancy over LPM.
Modification in the myelo-monocytic compartment results in
the PerC cellular renewal and improvement of nitric oxide
and IL-12 responses to a subsequent LPS stimulation
Given that peritoneal myelo-monocytic cell composition is
profoundly altered 48 h after zymosan and T. cruzi exposure, we
decided to examine the impact of this alteration for the renewal
and response of PC to a subsequent LPS stimulation. As it is well
established that senescent cells can accumulate in tissues
compromising tissue fitness [9–13,15], we compared b-Gal
expression, a marker of cell senescence [15], in PerC from control
and 48 h-zymosan or T. cruzi-exposed mice. For the enrichment of
cells from myelo-monocytic lineage (LPM and SPM within control
PerC; SPM and monocytes within stimulated PerC), only adherent
cells from PerC were analyzed (a cell population containing 98%
of MØ and/or monocytes – data not shown). While a great
majority of adherent PC from control mice was positive for b-Gal,
a significant reduction in the staining was observed in PC from
mice exposed to zymosan and T. cruzi (Fig. 3A). Moreover, the
frequency of b-Gal-positive cells in control mice correlated with
the frequency of LPM present among peritoneal MØ (Fig. 1 and
Fig. 2); this finding suggests that the majority of LPM is senescent.
In addition, adherent PC from control mice were unable to secrete
nitric oxide (NO), a potent microbicidal molecule, even after
subsequent LPS stimulation (Fig. 3B). Although adherent PC from
T. cruzi-exposed mice were able to secrete NO in the absence of
LPS, high levels of NO were found in LPS-stimulated PC from
both zymosan- and T. cruzi-exposed mice (Fig. 3B). As IL-12 is
involved in the ability of MØ to secrete NO in response to LPS
and IFN-c [26–30], we next examined the frequency of IL-12-
producing cells. After in vitro LPS stimulation, two to three times
higher frequencies of IL-12-producing cells were found within
myelo-monocytic cells from mice exposed to zymosan and T. cruzi
in comparison to the untreated control mice (Fig. 3C).
Figure 3. Zymosan and T. cruzi inoculation leads to PerC cellular renewal and improves local cell effector activities. C57BL/6 mice were
injected i.p. with zymosan (1 mg/mouse) or T. cruzi (10
6 parasites/mouse) and 48 h later PC from naive and injected mice were harvested and
cultured for 4 h. Non-adherent cells were removed by sequential washes. (A) b-Gal staining was performed as described in M&M. Slides were
analyzed by optical microscopy (406) and pictures were captured by Sony Camera (zoon 3.0). (B and C) Adherent PCs cells from 48 h-exposed mice
and controls were stimulated in vitro with media or LPS (1 mg/mL). (B) Nitrite concentrations in culture supernatants were determined by the Griess
reaction after 48 h of in vitro culture. Numbers represent the mean 6 SD of triplicate samples. ***p,0.001 in relation to non-stimulated group and
&&& p,0.001 when compared to the control group. (C) Frequencies of IL-12-producing F4/80
+ cells were evaluated by intracellular staining as
described in M&M. Bars indicate the standard deviation (SD). *** p,0.001 when compared to the control group. Data are representative of more than
3 independent experiments.
doi:10.1371/journal.pone.0022141.g003
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activated by exogenous stimuli
Next, we evaluated the individual contribution of myelo-
monocytic cell populations to the improvement of inflammatory
responses found in zymosan or T. cruzi-stimulated PerC. At an
early time point (30 min) after zymosan or T. cruzi exposure,
LPM and SPM were still the dominant myelo-monocytic cell
populations present in the PerC (Fig. 2A). At this time point,
h i g h e rn u m b e r so fz y m o s a np a r t i c l e sw e r ef o u n di n s i d eS P M
(Fig. 4A and 4B). Forty-eight hours after zymosan or T. cruzi
exposure, the frequency of SPM spontaneously producing IL-12
was similar to untreated controls. However, when stimulated
with LPS plus IFN-c in vitro we observed two to three times
more IL-12-producing SPM from zymosan- or T. cruzi-treated
mice compared to PBS-injected controls (Fig. 4C). Importantly,
the IL-12 response to LPS plus IFN-c was twice as high in SPM
from injected mice than in the respective infiltrating monocytes
(Fig. 4C). These data indicate that modifications in the
peritoneal myelo-monocytic compartment in response to
infectious stimuli include the emergence of a robust SPM cell
population.
Discussion
MØ represent a heterogeneous cell population that resides in
virtually all tissues of the body where they are able to assume a
wide range of immune functions. Depending on their activation
profile, these cells have been implicated in pathogen control and
the initiation of inflammatory processes, or, conversely, in the
regulation of these processes followed by restoration of tissue
homeostasis [17–21]. It is currently accepted that tissue-derived
factors influence MØ activation profiles. However, distinct MØ
subpopulations have been found in the same environment [1,5].
Consistent with this, we have recently described the coexistence of
large (LPM) and small (SPM) peritoneal MØ in the PerC [1].
Despite the distinct ex vivo and in vitro responses to LPS stimulation,
the in vivo behavior of SPM and LPM remain to be elucidated.
Here, we demonstrate that there is a clear alteration in the
frequencies of LPM and SPM during inflammatory responses to
zymosan and T. cruzi. At early time points after zymosan exposure,
although LPM remains the major peritoneal MØ subset, the PerC
is enriched with SPM. However, 48 h after zymosan and T. cruzi
stimulation, the cellular composition of the PerC is profoundly
altered by the disappearance of LPM and the accumulation of
Figure 4. SPM are more responsive than LPM and monocytes to infectious stimuli. C57BL/6 mice were injected i.p. with zymosan (1 mg/
mouse) or T. cruzi (10
6 parasites/mouse) and PCs were harvested 30 min or 48 h after stimulation. (A) SPM and LPM from C57BL/6 zymosan-exposed
mice were FACS-sorted 30 min after injection and the presence of internalized zymosan particles was observed by optical microscopy. Slides were
made with 10
5 cells from purified MØ subsets, stained with H&E and analyzed by optical microscopy (406). (B) Numbers represent the mean 6SD of
internalized zymosan particles per cell in each MØ subset. *** p,0.001 when compared to the LPM group. (C) PC from control or 48 h-exposed mice
were cultured for 6 h in the presence of brefeldin A with or without LPS (1 mg/ml) plus rIFN-c (5 ng/ml). Titles above plots indicate in vivo - in vitro
stimulations. Values inside gates represent the frequencies of IL-12-producing cells in each subpopulation. Data are representative of more than 3
independent experiments.
doi:10.1371/journal.pone.0022141.g004
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to lose the expression of the b-galactosamine senescence marker
while increase NO secretion and the frequency of IL-12-expressing
cells in response to subsequent LPS and IFN-c stimulation.
Peritoneal MØ have been extensively adopted for experimental
modelsbecauseof their easyenrichment and isolation from the PerC.
However, we and others have demonstrated that a variety of cell
populations reside in the PerC, including B cells, DC, eosinophils,
mast cells, neutrophils, T cells, NK cells, and invariant NK T cells
[1,2,31]. Under steady state conditions, B-1 cells and MØ compose
the majority of PC [1]. We have recently proposed that resident MØ
are represented by two subsets, LPM and SPM [1].
The heterogeneity of resident peritoneal myelo-monocytic cells
was also reported by Dioszeghy et al. [31] who also defined two
distinct populations of MØ-like cells according to the expression of
12/15-lipoxygenase (LOX). Interestingly, these 12/15-LOX
+ and
12/15-LOX
2 MØ-like cells display distinct functional and
phenotypic properties. The 12/15-LOX
+ population expresses
higher levels of F4/80 and Scavenger Receptor (SR)-A and secrete
more IL-10 and G-CSF in response to Staphylococcus epidermis cell-
free supernatant (SES) than do 12/15-LOX
2 cells. This F4/
80
high12/15-LOX
+ subset was defined by authors as resident MØ
[31] and are present in the PerC at similar frequencies of LPM in
steady state conditions [(1) and (Fig. 1 and 2)]. Because they share
functional and phenotypic characteristics, F4/80
high12/15-LOX
+
subset and LPM may represent the same cell population.
On the other hand, we believe the F4/80
low12/15-LOX
2 cells
and SPM are different cell populations. Despite sharing the same
CD11b
+F4/80
lowMHCII
high phenotype, the expression of CD11c
distinguishes 12/15-LOX
2 cells and SPM. 12/15-LOX
2 cells
express high levels of the DC marker CD11c [31], whereas SPM
was selected among CD11c negative or very low cells (Fig. 1 and
[1]). In addition, SPM express lower levels of CD40, CD80 and
CD86 costimulatory molecules compared to LPM [(1) and
Table 1]. In comparison, 12/15-LOX
2 cells express higher levels
of these same co-stimulatory molecules than its counterpart 12/15-
LOX
+ cells [31].
However, because the expression of CD11c and other surface
markers is not homogeneous among DC and MØ subpopulations
and the fact that DC and MØ share many of their immune
functions [32,33], we consider the possibility that the discrimina-
tion between 12/15-LOX
2 cells and SPM may not be precise.
Therefore, we envision the possibility that these two populations
partially overlap and, accordingly, the presence of SPM within
F40/80
low12/15-LOX
2 cells and vice versa cannot be discarded.
As a dynamic compartment, the PerC recruits effector cells in
response to injury. Neutrophil and inflammatory monocyte infiltrates
are observed in response to stimuli such as LPS, thyoglicolate, SES or
zymosan [1,31,34,35]. A clear alteration in the frequencies of LPM
and SPM was observed after zymosan and T. cruzi stimulation. After
30 min of exposure, a modest SPM enrichment was observed.
However, their numbers were not significantly altered (data not
shown). In addition, at late time points after zymosan and T. cruzi
stimulation, granulocytes, monocytes and SPM appeared to account
for the increased cell numbers found in the PerC (Fig. 2B and data
not shown). Interestingly, SPM and monocyte enrichment was
accompanied by LPM disappearance from the PerC (Fig. 2). We
have shown that LPM disappearance in response to thyoglicolate
injection cannot be attributed to LPM differentiation into SPM [1].
However, the events underlying LPMdisappearance from stimulated
PerC that could include cell death or migration remain to be solved.
Many studies have been demonstrated the impact of immune-
senescence or age-related immune cell deficiency in MØ functions
[9–14]. For example, aging impairs production of NO [14] and
phagocytic capacity [9,10,12] of MØ and reduces their expression
of MHC class II [13]. LPM seem to exhibit morphological and
functional characteristics described in senescent cells, including
large size, prominent vacuolization (Fig. 1), reduced phagocytic
capacity (Fig. 4) and low expression of MHCII molecules (Fig. 1)
[9–14]. Furthermore, these senescent signs were accompanied by
defective NO production in vivo [1]. In this regard, the senescence
could be hypothesized to explain the rapid disappearance of LPM
from the PerC after stimulation. In fact, after zymosan and T. cruzi
exposure, adherent PC exhibited decreased b-Gal staining (Fig. 3)
[15], indicating that the loss of LPM correlates to the cell renewal
of the PerC. Despite the rapid loss of LPM in response to i.p.
stimuli, it is expected that these cells are retained in the tissue for
an immunological purpose. In fact, unpublished data from our
group demonstrated their marked ingestion of apoptotic cells
followed by IL-10 secretion, which suggest they have some early
sentinel role in PerC. Since LPM disappearance is accompanied
by the enrichment of SPM and monocytes, the PerC appears to be
repopulated with other myeloid subsets that are more competent
in disturbed milieus.
LPM, SPM and monocyte frequencies found in stimulated PerC
were influenced by the nature of the stimuli (Fig. 2). PC from
zymosan-stimulated mice exhibited Ly-6C
+ monocytes as the
dominant population, whereas SPM was the major myelo-
monocytic subset present in the PerC of T. cruzi-stimulated mice.
Since infiltrating SPM and monocytes display the same expression
of F4/80, these cells were distinguished by Ly-6C expression found
only in monocytes as well as the high levels of MHCII expressed
by SPM (Fig. 2). Infiltrated monocytes in PerC seem to display
reduced Ly-6C expression when compared to blood monocytes
[1], suggesting that these cells differentiate in PerC. Therefore, it is
not certain whether infiltrating SPM and monocytes represent two
distinct populations or, conversely they are the same population in
different maturation states. In our previous study, we found that
Ly-6C
+ monocytes infiltrate the PerC in response to thyoglicolate
injection and subsequently up-regulate MHCII expression resem-
bling SPM [1]. As Ly-6C
+ monocytes are believed to give rise to
inflammatory MØ [36], the putative origin of SPM could explain
the activated profile exhibited by SPM (Table 1 and Fig. 4).
Of note, independent of stimuli and SPM or monocytes
dominancy, stimulated-PC appear to be more easily responsive
to subsequent in vitro LPS stimulation as they secreted higher levels
of NO and exhibited higher frequencies of IL-12-positive cells.
Finally, SPM rather than LPM or monocytes, appear to be the
major source of IL-12 in response to a subsequent LPS plus IFN-c
stimulation. Moreover, exposure to infectious stimuli led to the
emergence of a robust SPM population exhibiting a higher
frequency of IL-12-positive cells in response to subsequent LPS
plus IFN-c stimulation when compared to SPM from untreated
mice (Fig. 4). Since IL-12 has been described as an important
element for driving the polarization of peritoneal MØ towards M1
activation profile and the consequent capacity of these cells to
produce NO in response to LPS and IFN-c [26–30], we might
propose that in inflammatory conditions PerC is enriched with a
primed and easily activated MØ population, which could improve
microbicidal responses within this environment.
Thus, the substitution of LPM by SPM and monocytes greatly
improves local cell responses to subsequent stimuli. However, lack
of experimental models with conditional depletion of MØ subsets
prevents us to determine the relative roles of LPM, SPM and
monocytes for host protection against infections. Taken together,
our data suggest that the infectious stimuli induce the disappear-
ance of senescent LPM, the infiltration of monocytes and the
emergence of a robust SPM subset; which collectively provides
Dynamics of Peritoneal Macrophage Subsets
PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22141cellular renewal and lead to an improvement in the PerC response
to a subsequent LPS and IFN-c stimulation.
Supporting Information
Figure S1 SSC profile discriminates granulocytes and
peritoneal MØ subsets.( A) Granulocytes present a particular
SSC profile (Gray dots, total PC; Black dots, indicated F4/80
+
population), which were used for their exclusion in sequential
analysis. (B) Plots show the sequential gates used for the exclusion
of granulocytes and the subsequent identification of LPM and
SPM. Experiments were repeated 3 times, showing similar profiles.
(TIF)
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